Nelli Morgulchik
Investor at Hummingbird Ventures
Nelli Morgulchik
Investor at Hummingbird Ventures
London Area, United Kingdom
Overview
Work Experience
Investor - Biotech
2024 - Current
Investing in early-stage bio companies across the globe - Pre-Seed to Series A 🧬 Our bio companies include BillionToOne, Enveda Biosciences, Serna Bio, Waypoint Bio, Kernal Biologics, Automata, Basecamp Research, LatchBio, Kaleidoscope Bio, Amber Bio and Pheiron.
Venture Development Associate
2022 - 2023
• Managed and delivered bespoke Accelerator Programmes for 100+ early-stage start-ups across life sciences and healthcare, providing commercial de-risking support and coaching • Expanded the ecosystem and partnerships by engaging with experts for mentorship and due diligence, and overseeing operational management, resulting in increased resources and support for startups
Strategy & Partnerships Associate
2021 - 2022
• Formulated B2B sales strategy, set up >0.5B sales pipeline and onboarded sales executives • Managed a cross-functional team in the conceptualization and development of a new B2B product offering • Validated hypotheses through collecting and synthesizing customer data for product and marketing teams • Assisted C-suite in fundraising (preparing the grant application and pitch deck, building financial models)
Analyst
2020 - 2021
• Drove market research across 10+ developed and emerging markets to deliver recommendations for product launch, value and access, life cycle management strategies as well as portfolio innovative contracting strategies • Sharpened expertise and awareness across multiple therapeutic areas including oncology, infectious and rare diseases • Engaged in thought leadership and podcast development on the pharmaceutical and biotech industry trends
Researcher
2020 - 2020
Polygeia is a student-led global health think tank from the UK that created a COVID-19-focused research group - Student Collaborative for Extempore Research on COVID-19 (SCERC). • Conducted a systematic review on differences in risk, presentation and outcomes of COVID-19 in cancer patients across the world, published in Clinical Oncology
Project Manager
2020 - 2020
Imperial Consulting Group is a non-profit strategy consulting firm run by high-performing students from Imperial College London. • Developed a market entry strategy for a novel dry eye disease diagnostic device pioneered by Tear Diagnostics, a spinout company from the Department of Chemical Engineering at Imperial College London
Summer Associate
2019 - 2019
applied strategic is a leading life science and pharmaceutical consultancy with 15+ years of experience. • Delineated an opportunity for a new oral diabetes product in US/Europe with a potential value of $500+ million, analysed 150+ scientific and commercial resources, wrote a 45+ page executive report and drafted a patent application for European Patent Office
Vice Chair
2018 - 2019
Building Bridges in Medical Sciences is a one-day conference that brings together scientists from different disciplines, career stages and countries. The conference emphasises the need for interdisciplinary approaches to tackle the biomedical research and global health challenges of the 21st century. • Managed a team of 9 students organising a cross-disciplinary medical conference for 300+ postgraduate students with 8 acclaimed speakers from academia, industry, NGOs and start-ups • Launched a sponsorship campaign that secured £14,000+ from academic and corporate organisations
Co-Founder
2018 - 2019
• Organised a multidisciplinary team of 5 students developing an innovative wearable device - SenseBlock - to detect arterial re-narrowing in atherosclerosis with projected £5.5M in healthcare cost savings • Propelled the project to the semi-final of MedTech Venture Competition by the Judge Business School of the University of Cambridge beating 40+ emerging start-ups • Received an offer to join Accelerate Cambridge incubator
Leader of Tomorrow
2018 - 2018
GapSummit is an annual student-run, world-class biotechnology leadership summit organised by Global Biotech Revolution with the core objectives of substantively discussing pressing challenges facing the bio-economy and catalyzing innovation to solve these challenges. • Selected among 100 students and early career professionals in pharmaceutical and biotechnological industries worldwide • Proposed a blockchain-based solution to fight health insurance fraud in the US, generated a 2-page business plan and prepared a pitch for the bio-innovation competition, Voices of Tomorrow